Full-size Left-side Hidden
REFERENCES

1. Hargarten SW, Baker TD, Guptill K: Overseas fatalities of United States citizen travelers: an analysis of deaths related to international travel 2. Ann Emerg Med  1991; 20:622-626.

2. Nordberg E: Injuries as a public health problem in sub-Saharan Africa: epidemiology and prospects for control. East Afr Med J  2000; 77(12 Suppl):S1-S43.

3. Petridou E, Askitopoulou H, Vourvahakis D, et al: Epidemiology of road traffic accidents during pleasure travelling: the evidence from the Island of Crete. Accid Anal Prev  1997; 29:687-693.

4. Centers for Disease Control and Prevention (CDC) : Alcohol use and aquatic activities - United States, 1991. MMWR Morb Mortal Wkly Rep  1993; 42:681-683.

5. Hawkes S, Hart GJ, Johnson AM, et al: Risk behaviour and HIV prevalence in international travellers. AIDS  1994; 8:247-252.

6. Hogh B, Clarke PD, Camus D, et al: Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Lancet  2000; 356:1888-1894.

7. Overbosch D, Schilthuis H, Bienzle U, et al: Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis  2001; 33:1015-1021.

8. von Sonnenburg F, Tornieporth NG, Waiyaki P, et al: Risk and aetiology of diarrhoea at various tourist destinations. Lancet  2000; 356:133-134.

9. Pitzinger B, Steffen R, Tschopp A: Incidence and clinical features of travelers' diarrhea in infants and children. Pediatr Infect Dis J  1991; 10:719-723.

10. Steffen R, Collard F, Tornieporth N, et al: Epidemiology, aetiology and impact of travellers' diarrhea in Jamaica. JAMA  1999; 281:811-817.

11. Stermer E, Lubezky A, Potasman I, et al: Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis  2006; 43:898-901.

12. Gomi H, Jiang ZD, Adachi JA, et al: In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother  2001; 45:212-216.

13. Jiang ZD, Lowe B, Verenkar MP, et al: Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis  2002; 185:497-502.

14. Ericsson CD: Travelers' diarrhea: epidemiology, prevention and self-treatment. Infect Dis Clin North Am  1998; 12:285-303.

15. Mattila L, Siitonen A, Kyronseppa H: Risk behaviour for travelers' diarrhea among Finnish travelers. J Trav Med  1995; 2:77-84.

16. DuPont HL, Ericsson CD: Prevention and treatment of travelers' diarrhea. N Engl J Med  1993; 328:1821-1827.

17. DuPont HL, Jiang ZD, Okhuysen PC, et al: A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med  2005; 142:805-812.

18. Peltola H, Siitonen A, Kyronseppa H, et al: Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet  1991; 338:1285-1289.

19. Wingate D, Phillips SF, Lewis SJ, et al: Guidelines for adults on self-medication for the treatment of acute diarrhoea. Aliment Pharmacol Ther  2001; 15:773-782.

20. Mattila L: Clinical features and duration of travelers' diarrhea in relation to its etiology. Clin Infect Dis  1994; 19:728-734.

21. De Bruyn G, Hahn S, Borwick A: Antibiotic treatment for travellers' diarrhoea (Cochrane review). Cochrane Database Syst Rev  2000.CD002242.

22. Steffen R: Worldwide efficacy of bismuth subsalicylate in the treatment of travelers' diarrhea. Rev Infect Dis  1990; 12(suppl 1):S80-S86.

23. DuPont HL, Ericsson CD, Mathewson JJ, et al: Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea. Digestion  1998; 59:708-714.

24. Muentener P, Schlagenhauf P, Steffen R: Imported malaria (1985-95): trends and perspectives. Bull World Health Organ  1999; 77:560-566.

25. Behrens RH, Bisoffi Z, Björkman A, et al: Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent. Malar J  2006; 5:1-7.

26. Hay SI, Rogers DJ, Toomer JF, et al: Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, internet access and review. Trans R Soc Trop Med Hyg  2000; 94:113-127.

27. Rutledge LC, Gupta RK, Mehr ZA, et al: Evaluation of controlled-release mosquito repellent formulations. J Am Mosq Control Assoc  1996; 12:39-44.

28. Schoepke A, Steffen R, Gratz N: Effectiveness of personal protection measures against mosquito bites for malaria prophylaxis in travellers. J Trav Med  1998; 5:188-192.

29. Meier CR, Wilcock K, Jick SS: The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials. Drug Saf  2004; 27:203-213.

30. Ohrt C, Richie TL, Widjaja H, et al: Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomised, double-blind, placebo-controlled trial. Ann Intern Med  1997; 126:963-972.

31. Frost P, Weinstein GD, Gomez EC: Phototoxic potential of minocycline and doxycycline. Arch Dermatol  1972; 105:681-683.

32. Schuhwerk M, Behrens RH: Doxycycline as first line malarial prophylaxis: how safe is it?. J Trav Med  1998; 5:102.

33. Shanks GD, Kremsner PG, Sukwa TY, et al: Atovaquone and proguanil hydrochloride for the chemoprophylaxis of malaria. J Trav Med  1999; 6(suppl 1):S21-S27.

34. Hill DR, Baird JK, Parise ME, et al: Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg  2006; 75:402-415.

35. WHO : International Travel and Health,  Geneva, World Health Organization, 2001.

36. Schlagenhauf P, Steffen R, Tschopp A, et al: Behavioural aspects of travellers in their use of malaria presumptive treatment. Bull World Health Organ  1995; 73:215-221.

37. Jelinek T, Amsler L, Grobusch MP, et al: Self-use of rapid tests for malaria diagnosis by tourists. Lancet  1999; 354:1609.

38. Whitty CJM, Armstrong M, Behrens RH: Self-testing for falciparum malaria with antigen-capture cards by travellers with symptoms of malaria. Am J Trop Med Hyg  2000; 63:295-297.

39. Mulhall BP: Sex and travel: studies of sexual behaviour, disease and health promotion in international travellers - a global review. Int J STD AIDS  1996; 7:455-465.

40. Bloor M, Thomas M, Hood K, et al: Differences in sexual risk behaviour between young men and women travelling abroad from the UK. Lancet  1998; 352:1664-1668.

41. Eichmann A: Sexually transmissible diseases following travel in tropical countries. Schweiz Med Wochenschr  1993; 123:1250-1255.

42. Bonneux L, Van der Stuyft P, Taelman H, et al: Risk factors for infection with human immunodeficiency virus among European expatriates in Africa. BMJ  1988; 297:581-584.

43. de Graaf R, van Zessen G, Houweling H, et al: Sexual risk of HIV infection among expatriates posted in AIDS endemic areas. AIDS  1997; 11:1173-1181.

44. Savarit D, De Cock KM, Schutz R, et al: Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city. BMJ  1992; 305:498-502.

45. Mutsch M, Spicher V, Gut C, et al: Hepatitis A virus infections in travelers, 1988-2004. Clin Infect Dis  2006; 42:490-497.

46. Mahon BE, Mintz ED, Greene KD, et al: Reported cholera in the United States, 1992-1994: a reflection of global changes in cholera epidemiology. JAMA  1996; 276:307-312.

47. Zuckerman JN, Steffen R: Risks of hepatitis B in travellers as compared to immunisation status. J Trav Med  2000; 7:170-174.

48. Bernard KW, Fishbein DB: Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost?. Vaccine  1991; 9:833-836.

49. Khromava AY, Eidex RB, Weld LH, et al: Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine  2005; 23:3256-3263.

50. Taha MK, Achtman M, Alonso JM, et al: Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet  2000; 356:2159.

51. Centers for Disease Control (CDC) : Imported bubonic plague. MMWR Morb Mort Wkly Rep  1990; 39:895-901.

52. Cobelens FG, van Deutekom H, Draayer-Jansen IW, et al: Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet  2000; 356:461-465.

53. Moore M, Valway SE, Ihle W, et al: A train passenger with pulmonary tuberculosis: evidence of limited transmission during travel. Clin Infect Dis  1999; 28:52-56.

54. Mutsch M, Tavernini M, Marx A, et al: Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis  2005; 40:1282-1287.

55. Lifson AR: Mycobacterium tuberculosis infection in travellers: tuberculosis comes home. Lancet  2000; 356:442-443.

56. Whitty CJM, Macallan DC, Lewis DJM: Use of BCG vaccination. Lancet  2000; 356:1609-1610.